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ABSTRACT
The specificity of protein–nucleic acid recognition
is believed to originate largely from hydrogen bond-
ingbetweenproteinpolaratoms,primarilyside-chain
and polar atoms of nucleic acid bases. One way to
design new nucleic acid binding proteins of novel
specificity is by structure-guided alterations of the
hydrogen bonding patterns of a nucleic acid–protein
complex. We have used cI repressor of bacterio-
phage l as a model system. In the l-repressor–DNA
complex, the «-NH2 group (hydrogen bond donor)
of lysine-4 of l-repressor forms hydrogen bonds
with the amide carbonyl atom of asparagine-55
(acceptor) and the O6 (acceptor) of CG6 of operator
site OL1. Substitution of lysine-4 (two donors) by iso-
steric S-(2-hydroxyethyl)-cysteine (one donor and
one acceptor), by site-directed mutagenesis and che-
mical modification, leads to switch of binding speci-
ficity of l-repressor from C:G to T:A at position 6
of OL1. This suggests that unnatural amino acid
substitutions could be a simple way of generating
nucleic acid binding proteins of altered specificity.
INTRODUCTION
A structural understanding of protein–nucleic acid interaction
has advanced sufﬁciently for creation of engineered and
artiﬁcially evolved DNA-binding proteins for some DNA
sequences (1). Designed zinc ﬁnger proteins are now being
applied for cell engineering and therapeutic purposes in some
cases (2). However, a simple strategy for creating new nucleic
acid binding proteins, in general, is still beyond reach. For
example, an understanding of RNA recognition has not yet
reached the sophistication needed for engineering RNA-
binding proteins of novel speciﬁcity. A simple stereochemical
rule for creating new recognition points on an existing protein
or peptide scaffold would be of great beneﬁt for designing
RNA-binding proteins of novel speciﬁcity and allow creation
of more diversiﬁed DNA-binding protein modules as well.
Several studies have looked into alterations and relaxations
of speciﬁcity by mutating critical residues (substitution with
natural amino acids). Some of these effects are weak (3–6).
However, in other cases a speciﬁcity difference of several
orders of magnitude is seen (7–13). Ebright et al. (7), Wharton
and Ptashne (8) and Youderian et al. (9), reported that a
single amino acid change in the recognition helix changes
the binding speciﬁcity for a mutant operator by several orders
of magnitude. Wharton and Ptashne (10) demonstrated that
by changing the recognition helix of 434 repressor to that of
the P22 repressor, by introducing several mutations, it is pos-
sible to completely switch the binding speciﬁcity from 434
operator to that of P22 operator. In many cases, recognition
speciﬁcity is based on hydrogen bonding between amino
acid side chains and nucleic acid bases, particularly with sub-
stituents in position 6 in purine and position 4 in pyrimidine.
Base substitution within the same class (that is purine to
purine and pyrimidine to pyrimidine) approximately preserves
the size and shape of the base with concomitant switch of
hydrogen bond donors to acceptors or vice versa in these
positions. An example of such a switch is the position 6 of
the purine ring which changes from a hydrogen bond donor
(–NH2) in adenine to a nearly iso-steric (sterically equivalent)
hydrogen bond acceptor (6-Oxo) in guanine. Thus, if an
adenine is recognized at the 6-amino group by an amino
acid side-chain, which is a hydrogen bond acceptor, substitu-
tion of an iso-steric amino acid with hydrogen bond donor
properties may recognize guanine in place of adenine or vice
versa. Such a simple substitution rule may allow relatively
simple engineering of novel recognition speciﬁcity.
As a test case, we chose l-repressor–OL1 complex to test
the above-mentioned idea. Lysine-4 of l-repressor is a crucial
residue from point of view of operator recognition. In con-
junction with Asn-55 it recognizes base pair CG6. Lysine-4
forms a crucial hydrogen bond with CG6, in which it recog-
nizes the 6-Oxo group of the guanine by hydrogen bond dona-
tion from the e-NH2 group (Figures 1 and 2) while Asn-55
donates a hydrogen bond to purine N7 of CG6 base pair (14).
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between lysine-4 amino group and the side-chain carbonyl
of Asn-55. If a TA base pair is substituted for CG6, an
amino group replaces the oxo group at the 6 position of the
purine ring, while retaining other recognition points. The two
hydrogen atoms of this amino group make this group a hydro-
gen bond donor and may be recognized by a hydrogen bond
acceptor, otherwise iso-steric with lysine-4. An ideal iso-steric
group with above-mentioned properties will be where the
e-NH2 group of lysine is replaced by a hydroxyl group
(Figure 1). This will also preserve the hydrogen bond between
lysine-4 and Asn-55, thus preserving the recognizing pair.
Site-speciﬁc incorporation of such a lysine analog would
involve either chemical synthesis or nonsense codon suppres-
sion, both of which could be cumbersome (15,16).
Modiﬁcation of a cysteine that has been introduced by site-
directed mutagenesis has been used as a strategy to introduce
unnatural amino acids. In several cases mutation to a chemi-
cally similar amino acid has been used to derive the stringent
requirement of a particular amino acid (17–22). We developed
a strategy to create an amino acid, which is iso-steric with
lysine but chemically dissimilar, through side-chain modiﬁca-
tion of a reactive cysteine. In this paper, we demonstrate that
such a semi-synthetic repressor indeed recognizes the mutated
DNA sequence.
MATERIALS AND METHOD
Materials
Acrylamide, bisacrylmide, TEMED, phenylmethylsulfonyl
ﬂuoride (PMSF), ethidium bromide, 2-iodoethanol, bromo-
phenol blue, Commassie brilliant blue, hydroxylapatite,
QAE–Sephadex A-50, Sephadex G-25, streptavidine agarose,
EDTA, DTNB, DTT, BSA and ampicillin were purchased
from Sigma chemical Co. Tryptone and yeast extract was
purchased from Himedia Laboratories Pvt. Ltd (India).
Magnesium chloride, sodium chloride, calcium chloride,
2-mercaptoethanol, glycerol and Tris were purchased from
E-Merck (India). X-gal, isopropyl-b-D-thiogalactopyranoside
(IPTG), sodium MOPS, agarose, triethanolamine and SDS
were purchased from SRL (India). N-iodoacetyl-N-biotinyl-
hexylenediamine was purchased from Pierce (USA). Res-
triction enzymes and T4 DNA ligase were purchased from
Boehringer Mannheim and GIBCO BRL. Taq DNA poly-
merase primers and dNTPs were purchased from Genei
(Bangalore, India). 50-Amino linked oligonucleotides were
from Microsynth (Switzerland).
Site-directed mutagenesis
The mutation from lysine-4 to cysteine-4 was performed by
site-directed mutagenesis of the cI gene using PCR. A mutant
upstream primer containing EcoRI site (50-GTA TAG AAT
TCACGT ATG AGC ACA AAA TGC AAA CCA TT-30) and
a downstream primer complementary to non-coding region
containing a BamHI site (50-ACC ATT CTT CAT AAT
TGG ATC CAT TTA CTA TG-30) were used. The PCR
was carried out in 0.5 ml Perkin-Elmer microcentrifuge
tube. The reaction mixture was prepared by mixing template
DNA, primers, dNTPs, Taq DNA polymerase and the reaction
buffer (supplied by the manufacturer).
The reaction was carried out in Perkin-Elmer GeneAmp
PCR System 2400 (USA) DNA thermal cycler. The PCR
product was run in 1% agarose gel and the desired DNA
band was cut. The PCR product was extracted using QIAGEN
gel extraction kit (Qiagen, Germany). PCR product and plas-
mid vector were digested with restriction enzymes EcoRI and
BamH1 following GIBCO BRL protocol. Ligation was carried
out using T4 DNA ligase. Digestion of DNA with restriction
endonucleases was carried out at 37 C for 3 h, in the buffer
supplied by the manufacturer. The ligation of the EcoRI and
BamH1 digested PCR product with the EcoRI and BamH1
digested pUC-19 vector was carried out at 23 C for 3 h using
T4 DNA ligase. The ligated plasmid was transformed into
competent DH5-a cells and colonies selected by blue-white
selection. Five colonies were picked. One of those ﬁve
Figure 1. Upper panel shows the hydrogen bonding pattern of CG6 with
lysine-4 and hydrogen bonding of lysine-4 with Asn-55. Lower panel
is the hypothetical hydrogen bonding pattern of the mutant TA6 and
S-(2-hydroxyethyl)-cysteine-4, along with Asn-55.
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and the desired mutation at K4C was conﬁrmed. This plasmid
having K4C l-repressor gene was named pAM 109.
pAM109andpKK223-3plasmidswere digestedwithEcoRI
and PstI restriction enzymes. The restriction fragment con-
taining K4C gene was extracted from digested pAM109
using QIAGEN gel extraction kit following their protocol.
The K4C gene was ligated into digested pKK 223-3 using
Boerhinger Mannheim’s rapid ligation kit. The ligated product
was transformed in Escherichia coli XL-1 blue lac I
q strain
following the previous method. Cells were grown on ampicilin
Luria Agar plates at 37 C. Clone bearing colonies were con-
ﬁrmed through (i) plasmid isolation followed by agarose gel
electrophoresis, (ii) restriction digestion of the plasmid by
EcoR1 and Pst1 restriction enzymes and (iii) after IPTG
induction the over expression of 26 kDa protein in 15%
SDS–polyacrylamide gel. Cells from one of the cloned
colonies were stored in 20% glycerol at  80 C and the
corresponding plasmid was named pAM209.
Isolation and characterization of K4C l-repressor
K4C l-repressor protein was isolated from E.coli XL-1 blue
strain carrying the plasmid pAM209, which contains Lys to
Cys mutation at the 4th amino acid under the control of tac
promoter. The cells were grown at37 C,upto A590 ¼ 0.6, then
IPTG at a ﬁnal concentration of 1 mM was added and grown
further for 2 h. The cells were then harvested by centrifugation
at 12000 r.p.m. for15 min and were re-suspended using 1.7 ml
lysis buffer per gram of wet packed cells (SLA-1500). The cell
Figure 2. Crystal structure of l-repressor N-terminal domain crystal structure complexed with OL1. Lysine-4 is shown in green and asparagine-55 is shown in
cyan. The base pair CG6 is shown in space filling representation. Lower panel depicts the sequence of OL1. The top half is the consensus half. Of the two strands,
the top of left strand is the 50 end.
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according to Johnson et al. (23), with some modiﬁcations.
All volumes and amounts in the following puriﬁcation have
been normalized to 5 g of the starting cells. All steps were
carried out at 0–4 C unless stated otherwise.
Frozencells were thawed, suspended in 25 ml of lysis buffer
containing 20 mg/ml of PMSF and disrupted by sonication.
After sonication, (200 W; 30 s each time; 5 times with 5 min
gap) the crude lysate was diluted to 100 ml by SB (23) con-
taining 200 mM KCl and cellular debris were removed by
centrifugation at 12000 r.p.m. for 50 min. The repressor
was precipitated with gradual addition of 5 ml of 10% poly-
ethyleneimine, stirred for 1 h and precipitate was collected
by centrifugation at 10000 r.p.m. for 10 min. The polyethy-
leneimine pellet was re-suspended in 75 ml of SB containing
200 mM KCl and centrifuged at 10000 r.p.m. for 10 min.
Thenthe pelletwasagainre-suspended in50mlofSBcontain-
ing 600 mM KCl, stirred for 10 min and centrifuged at
10000 r.p.m. for 10 min. The supernatant containing the
repressor was saved.
Repressor in the decanted supernatant was precipitated by
gradual addition of 40 g of solid ammonium sulfate per 100 ml
of the supernatant (i.e. 80% saturated) and pH was maintained
at 8.0 by adding 3N KOH. The ammonium sulfate suspension
was stirred for 2 h and the precipitate was collected by cen-
trifugation at 13000 r.p.m. for 45 min. The ammonium sulfate
pellet was re-suspended in 5 ml of SB containing 50 mM KCl
and was dialyzed overnight against 500 ml of SB containing
50 mM KCl. The dialyzed material was centrifuged at
12000 r.p.m. for 10 min to remove any precipitated protein.
The supernatant containing the repressor was mixed with
50 ml of SB containing 100 mM KCl and 50 ml of pre-swollen
QAE–Sephadex A-50 in SB containing 100 mM KCl and the
mixture was stirred for 2 h at 4 C. It was then poured into a
glass column and allowed to settle. The protein was eluted
with a liner gradient of 150 ml of SB containing 100 mM KCl
and 150 ml of SB containing 600 mM KCl. Flow rate was
0.5 ml/min and 6 ml fractions were collected. Fractions
containing mutant repressor were identiﬁed by SDS–PAGE.
The pooled fractions containing the mutant repressor were
loadedon to a hydroxylapatitecolumn andeluted by a gradient
of 0.1–1.0 M potassium phosphate buffer (pH 6.8) contain-
ing 1.5 mM 2-mercaptoethanol (100 + 100) ml, ﬂow rate was
0.5 ml/min and 3 ml fractions were collected. The mutant
repressor pulled from the hydroxylapatite column was
 98% pure by criterion of electrophoresis on 15% SDS–
polyacrylamide gel and gave dark single band (24) corre-
sponding to a molecular weight of  26000 Da. The native
repressor concentration was determined by using E
1%
(280) ¼ 11.3 (25). Molar concentration was always calculated
in terms of monomer subunit unless stated otherwise.
Determination of sulfhydryl content
K4C l-repressor protein was mixed with 5 mM DTT and was
kept for 1 h at 4 C and exhaustively dialyzed against degassed
0.1 M potassium phosphate buffer (pH 8.0) containing 1 mM
EDTA. The protein solution was placed in a sample cuvette
and the dialysate buffer was placed in a reference cuvette
of a double-beam spectrophotometer. 5,50-Dithiobis(2-
nitrobenzoic acid) (DTNB) reacts with free sulfhydryl
groups of proteins to form thionitrobenzoate anion for each
–SH group. The concentration of this strongly colored
anion is determined from its absorbance at 412 nm (e ¼
13600 M
 1 cm
 1 at pH 8). DTNB solution was added to
each cuvette to a ﬁnal concentration of 0.1 mM and the reac-
tion was followed for 30 min. The determination of exposed
cysteines of K4C l-repressor proteins were followed at 6 mM
protein by reaction with 0.1 mM DTNB.
Chemical modification of K4C by 2-iodoethanol
A total of 50 ml of 100 mM DTT (ﬁnal concentration 3.3 mM)
was added to 1.5 ml K4C l-repressor protein (50 mM stock)
and was kept for 2 h at 4 C. A 25 ml Sephadex G-25 column
was equilibrated with the required amount of degassed reac-
tion buffer [50 mM triethanolamine–HCl (pH 7.8) containing
50 mM NaCl, 1 mM EDTA and 10% glycerol]. Then the DTT
and protein mixture was passed through a Sephadex G-25
column using the above-mentioned buffer to remove excess
DTT and the reduced K4C l-repressor was collected as 1.2 ml
fractions. The fractions containing K4C l-repressor were
pooled in a screw cap glass vial (5 ml of 13 mM protein).
The reaction between K4C l-repressor and 2-iodoethanol
was performed at 27 C. A total of 6 ml 2-iodoethanol was
added into the reaction mixture under stirring conditions,
three times with 2 h interval. The reaction was allowed to
continue for 6 h and the ﬁnal 2-iodoethanol concentration
was 45 mM. After 6 h, iodoacetyl biotin derivative at a
ﬁnal concentration of 300 mM was added to the reaction
mixture and the reaction was allowed to proceed. After 1 h,
another fresh addition of iodoacetyl biotin to a ﬁnal concen-
tration of 150 mM (not counting the previous addition) was
added and the reaction was allowed to proceed for another 1 h.
ThenexcessDTTwas added andwaskept for1h.Thereaction
mixture was dialyzed against 1 litre degassed reaction buffer
to remove excess DTT, 2-iodoethanol and the unreacted
iodoacetyl biotin derivative followed by three dialysis against
degassed 0.1 M potassium phosphate buffer (pH 8) containing
1 mM EDTA. A total of 500 ml streptavidine agarose was
equilibrated with 0.1 M potassium phosphate buffer (pH 8)
containing 1 mM EDTA. The dialyzed modiﬁed l-repressor
was mixed with 500 ml of pre-equilibrated streptavidine agar-
ose and stirred for 10 min. Then the mixture was placed in a
spin column and the iodoethanol modiﬁed K4C l-repressor
was separated from the mixture by centrifugation. The pre-
sence offree –SHgroupwas measuredby DTNB reaction. The
chemical modiﬁcation at desired position was conﬁrmed by
DTNB test and N-terminal sequencing of the modiﬁed protein.
Circular dichroism (CD)
To see if any secondary structural elements change in the
modiﬁed K4C l-repressor, the far UV-CD spectra of modiﬁed
K4C l-repressor and wild l-repressor were measured in a
JASCO J-600 spectropolarimeter in a 1 mm path length cuv-
ette at 25 C, between 250 and 200 nm. The bandwidth was
2 nm and scan speed was 20 nm/min. Samples were prepared
at 50 mM Tris–HCl buffer (pH 7.5), containing 0.1 mM
EDTA and 200 mM KCl and the protein concentration
were modiﬁed 2.4 mM for K4C l-repressor and 2 mM for
wild-typel-repressor.Theresultsare reported asmeanresidue
ellipticity, with the unit of deg cm
2 dmol
 1.
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The wavelength maximum of tryptophan ﬂuorescence of
modiﬁed K4C l-repressor (concentration 2.4 mM) and wild
l-repressor (concentration 2 mM) were measured in a Hitachi
F3010 spectroﬂuorometer at 25 C and the experiments were
carried out in 1 cm pathlength quartz cuvette. The buffer was
50 mM Tris–HCl (pH 7.5), containing 0.1 mM EDTA and
200 mM KCl. The excitation wavelength was at 295 nm, the
excitation and emission bandpasses were 10 nm each.
Fluorescein isothiocyanate (FITC) labeling of
oligonucleotide
Oligonucleotides with 50 amino link (X ¼ hexyl amino group)
were purchased from Microsynth (Switzerland). Sequence of
oligonucleotides were as follows: Operator OL1: 50-XTCGA-
CATACCACTGGCGGTGATATGGATCC-30 and 50-XGG-
ATCCATATCACCGCCAGTGGTATGTCGA-30; Mutated
OL1 (CG6 to TA at the consensus half site): 50-XTCGACA-
TACCACTGGCGATGATATGGATCC-30 and 50-XGGAT-
CCATATCATCGCCAGTGGTATGTCGA-30.
For preparation of FITC labeled, oligonucleotides were
labeled in 500 ml solution containing 1 M sodium carbonate/
bicarbonate buffer (pH 9): DMF:water [high-performance
liquid chromatography (HPLC) grade] ¼ 5:2:3. Reaction was
carried out for 20 h at 25 C. After incubation, the reaction was
loaded onto a Sephadex G-25 column [pre-equilibrated in
0.1 M phosphate buffer (pH 8.0)] and eluted with same buffer.
The oligonucleotides and their complementary strands were
annealed by heating at 80 C followed by cooling slowly at
room temperature.
Operator titration of wild l-repressor and
its iso-steric analogue
All ﬂuorescence studies were done in a Hitachi F3010 spectro-
ﬂuorometer at 25 C and the experiments were carried out in
1 cm pathlength quartz cuvette. Anisotropy experiments were
performed using Hitachi (650-10/40) polarization accessory.
The excitation wavelength was at 480 nm and emission was
at 530 nm, the excitation and emission bandpasses were 10 nm
each. Fluorescein labeled wild OL1 and mutated OL1 (the CG6
of consensus site has replaced by TA6) were titrated with
increasing concentrations of both wild-type l-repressor and
S-(2-hydroxyethyl)-cysteine containing l-repressor separately
upto 350 nM protein concentrations. Anisotropy values were
calculated at each point according to the equation and plotted
against different protein concentrations. The titrations were
performed in 50 mM Tris–HCl buffer (pH 7.5), containing
1 mg/ml BSA, 0.1 mM EDTA and 250 mM KCl. The binding
isotherms obtained were ﬁtted to a single site binding equation
of the dimer coupled with monomer–dimer equilibrium using
a MATLAB program written by the authors. The dimer–
monomer dissociation constant was taken as 20 nM.
RESULTS AND DISCUSSION
The strategy to create an S-(2-hydroxyethyl)-cysteine contain-
ing l-repressor at position 4 relies on the fact that l-repressor
has no reactive cysteines (26). Thus, site-directed mutation of
K4 to C, followed by reaction with 2-iodoethanol may create
an amino acid, which is almost iso-steric with lysine but hav-
ing an OH instead of the e-NH2. K4C mutant cI gene was
created by PCR using one mutagenic end primer and another
end primer. The mutation was conﬁrmed by sequencing of the
whole gene. The mutant gene expressed well and was puriﬁed
as described previously (25).
The mutant protein showed one reactive sulfhydryl group
per subunit upon reaction with DTNB (Table 1). The reaction
kinetics of C4 was rapid, indicating exposed nature of the
sulfhydryl group. The K4C l-repressor was labeled with
2-iodoethanol, followed by reaction with an iodoacetamido
derivative of biotin to block the unreacted sulfhydryl
groups. The reaction mixture was then passed through a col-
umn of streptavidin-agarose to remove all biotin-modiﬁed
protein. This leads to isolation of l-repressor that has
S-(2-hydroxyethyl) cysteine in both subunits. The puriﬁed
S-(2-hydroxyethyl)-cysteine-4 containing l-repressor was
characterized by ten rounds of N-terminal Edman sequencing,
CD and ﬂuorescence spectroscopy. N-terminal sequencing
revealed an unknown amino acid at position 4, while the
other nine are consistent with the wild-type sequence.
l-repressor has three tryptophans at 129, 142 and 230. They
are sensitive probes of the tertiary structure of the protein.
Figure 3 shows the tryptophan emission spectra of the
wild-type and S-(2-hydroxyethyl)-cysteine-4 l-repressor. The
emission maximum and ﬂuorescence intensities (after correc-
tions for concentration differences) are very similar (emission
maximum of 339 nm in both cases), indicating no signiﬁcant
changes in the tertiary structure due to modiﬁcation. The
tryptophans in l-repressor are all situated in or around the
Table 1. Reaction of K4C and wild-type l-repressor with DTNB
Type of
protein
Protein
concentration
(mM)
Observed
OD412
No. of exposed
–SH group/subunit
K4C 6 0.083 1.04
Wild type 6 0.019 0.23
Figure 3. Fluorescence emission spectra of wild-type (solid line; 2 mM) and
S-(2-hydroxyethyl)-cysteine-4l-repressor(dashedline;2.4mM).Experimental
details are in Materials and Methods.
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there. The DNA-binding N-terminal domain is devoid of
tryptophan but consists of several helices. The far UV-CD
spectrum of the whole protein is dominated by the
N-terminal helices (26) and thus the CD spectra is a sensitive
monitor for the conformation of the N-terminal domain.
Figure 4 shows the CD spectra of the wild-type and the
S-(2-hydroxyethyl)-cysteine-4 l-repressor. The spectra are
similar indicating that there is no signiﬁcant conformational
perturbation in the N-terminal domain due to mutation and
chemical modiﬁcation. Taken together, we may conclude
that the protein remains in native-like conformation.
Fluorescence anisotropy is now widely used to study
protein–DNA interaction (27). Figure 5 shows binding of
wild-type l-repressor with wild-type OL1 operator site con-
taining oligonucleotide duplex. The binding was measured
by ﬂuorescence anisotropy of an attached ﬂuorescein probe
to the 50 ends of the duplex oligonucleotide. The binding was
conducted at somewhat elevated ionic strengths to offset any
possible non-speciﬁc binding. The ionic strength used is not
incompatible with physiological conditions. The binding iso-
therm was ﬁtted to a binding equation as described in Koblan
and Ackers (28,29). The initial anisotropy of the duplex
oligonucleotide and amplitude of increase is consistent with
those obtained previously (30). The dissociation constant thus
obtained was 56.2 nM for wild-type repressor dimer–OL1
complex. The dissociation constant of a similar synthetic
OR1 containing oligonucleotide–wild-type l-repressor com-
plex was determined by isothermal titration microcalorimetry
and found to be 4.2 nM at 210 mM monovalent salt and
pH 7.0 (31). Koblan and Ackers (28,29) have determined
dissociation constant of OR1–wild-type l-repressor complex
as a function of monovalent salt concentration and pH. After
extrapolation of dissociation constant obtained by micro-
calorimetry to 300 mM monovalent cation (including tris)
concentration and pH 7.5, a value of  35 nM was predicted
for the dissociation constant of OL1–wild-type l-repressor
complex at pH 7.5 and 300 mM monovalent cation (linear
extrapolation of data presented in Koblan and Ackers to
300 mM monovalent salt concentration yielded a factor of
three weakening when compared to that at 210 mM. Similar
extrapolation from pH 7.5 yields a factor of about four
weakening when compared to pH 7. This 12-fold difference
is then corrected for the small difference in afﬁnity for OL1
and OR1). This compares well with the dissociation constant
for OL1–wild-type l-repressor obtained (56.2 nM) by ﬁtting
the data shown in the upper panel of Figure 5.
Under identical conditions, wild-type l-repressor does not
bind the CG6!TA6 mutant operator (Figure 5). This is con-
sistent with base pair substitution experiments (32). Figure 5
also shows the binding of S-(2-hydroxyethyl)-cysteine-4
containing l-repressor with wild-type OL1. There is little
binding in the concentration range tested indicating impor-
tance of having a lysine e-NH2 in position 4. The deletion
of ﬁrst six amino acids of l-repressor abolishes operator
Figure 5. Upperpanel reflectstheanisotropyincreaseof50 fluoresceinlabeled
synthetic duplex oligonucleotide containing either wild-type OL1 operator site
(opencircles)orTA6mutant(solidcircles),withwild-typel-repressor.Lower
panel reflects the anisotropy increase with S-(2-hydroxyethyl)-cysteine-4
l-repressor. The symbols have the same meaning as above. The oligonucleo-
tides were end-labeled with fluorescein as described. The titration procedure
is also given in the Supplementary Data. Each point is an average of eight
independent titrations.
Figure 4. CD spectra of wild-type (solid line; 2 mM) and S-(2-hydroxyethyl)-
cysteine-4 l-repressor (dashed line; 2.4 mM). Experimental details are in
Materials and Methods.
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hydroxyethyl)-cysteine-4 modiﬁed l-repressor however
binds tightly to CG6!TA6 mutant OL1 as indicated by
increased anisotropy. When the binding isotherm was ﬁtted
to the binding equation, a dissociation constant of 9.82 nM
was obtained for S-(2-hydroxyethyl)-cysteine-4 modiﬁed
l-repressor complex. This indicates that S-(2-hydroxyethyl)-
cysteine-4 modiﬁed l-repressor regains all the binding energy
that is lost upon TA6 substitution.
Since both the dimers contain S-(2-hydroxyethyl)-
cysteine-4 modiﬁcations, while the mutant operator carries
only a mutation in the consensus half site, it is likely that
putative K4 interaction with the symmetrically related CG
pair in the non-consensus half site does not contribute signiﬁ-
cantly to the binding energy. This is consistent with the fact
that the N-terminal arm of the subunit that contacts the non-
consensus half site remains disordered even at low tempera-
tures in the crystal and substitution of a TA base pair in the
non-consensus half have little effect on the binding energy
(see Figure 2) (10,32).
Although the sterically equivalent substitution made here
is incorporated by chemical modiﬁcation, the enormous pro-
gress that is being made in recent years in incorporating
artiﬁcial amino acids in vivo (34) should allow us to soon
make non-natural iso-steric amino acid substitutions, in vivo,
with ease. This may open up new possibilities of engineering
new DNA-binding proteins and engineering of the genetic
programs, not hitherto accessible.
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